Molecular profile
Molecular profile
- Molecule class
- Synthetic peptide
- Origin
- Synthetic fragment
- Primary target system
- Aktin- und Zellmigrationsprozesse; Zuordnung produktabhängig
- Development stage
- Preclinical development
Bezeichnung für ein synthetisches Fragment beziehungsweise nicht einheitlich standardisierte thymosinbezogene Produkte.
Mechanism and signalling
Mechanism and signalling
Proposed effects are often extrapolated from thymosin beta-4 biology. Such extrapolation is not automatic because fragment identity, purity and formulation may differ.
Scientific classification
Scientific classification
This profile maps TB-500 to the research areas regeneration. Molecule class, evidence level, development stage and regulatory status are separated so that preclinical findings are not confused with authorised uses.
Peptides studied in models of cell migration, matrix organisation, wound healing and tissue repair.
Evidence base
Preclinical
Publicly available human evidence is limited. Any assessment must clearly distinguish the full endogenous peptide from fragments marketed as TB-500.
Regulatory status
Not generally authorised
This research substance has no general medicinal authorisation in Germany or the EU. Labels such as “research peptide” do not replace regulatory approval.
Safety and use notice
No dosing or administration recommendation
The available evidence does not establish safe self-directed use. This profile intentionally provides no dosing, sourcing or administration guidance.
Sources and registries